cbdMD (NYSEAMERICAN:YCBD) Shares Down 4.1% – Here’s What Happened

cbdMD, Inc. (NYSEAMERICAN:YCBD) fell 4.1% on Thursday . The company traded as low as $0.6850 and last traded at $0.7470. 173,155 shares traded hands during trading, a decline of 56% from the average session volume of 393,050 shares. The stock had previously closed at $0.7790.

cbdMD Price Performance

The firm’s fifty day moving average is $0.77 and its 200-day moving average is $0.92.

Institutional Investors Weigh In On cbdMD

A hedge fund recently bought a new stake in cbdMD stock. Jane Street Group LLC bought a new stake in cbdMD, Inc. (NYSEAMERICAN:YCBD) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 51,141 shares of the company’s stock, valued at approximately $69,000. Jane Street Group LLC owned 0.49% of cbdMD as of its most recent SEC filing. 7.18% of the stock is currently owned by institutional investors.

cbdMD Company Profile

cbdMD, Inc (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.

The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities.